DALLAS-FORT WORTH, TX — January 29, 2026 — In response to the recent Nipah virus (NiV) outbreak reported in India, BioStone Animal Health has launched a multi-species indirect ELISA (iELISA) Test kit for Nipah virus antibody detection (Cat. 10101), designed to support surveillance, biosecurity, and outbreak preparedness. Nipah virus is a highly pathogenic zoonotic virus with recurrent outbreaks…
DALLAS-FORT WORTH, TX— January 26, 2026 — BioStone Animal Health is pleased to announce the launch of the AsurDx™ Caseous Lymphadenitis (Corynebacterium pseudotuberculosis) Antibody ELISA Test Kit, designed for the detection of antibodies specific to Corynebacterium pseudotuberculosis in goat and sheep serum or plasma samples. About AsurDx™ CL Antibody ELISA Test Kit The AsurDx™ Caseous Lymphadenitis Antibody…
DALLAS-FORT WORTH, TX— November 21, 2025 — BioStone Animal Health is pleased to announce the launch of the AsurDxTM Trypanosoma Cruzi Real-Time PCR Detection Kit designed for the detection of Trypanosoma Cruzi (causative agent of Chagas Disease) in dog whole blood and feces. About Trypanosoma cruzi and Chagas Disease Chagas disease, caused by the parasite Trypanosoma cruzi, is a serious and potentially…
DALLAS-FORT WORTH, TX— October 3, 2025 — BioStone Animal Health is pleased to announce the launch of two new antibody detection kits designed for the equine market: the AsurDx™ Equine Herpesvirus (EHV) Antibody Test Kit and the AsurDx™ Equine Viral Arteritis (EVA) Antibody Test Kit. These ELISA-based kits provide veterinarians, laboratories, and researchers with rapid, sensitive,…
DALLAS-FORT WORTH, TX— May 30, 2025 — BioStone Animal Health is proud to announce a comprehensive solution for Foot-and-Mouth Disease (FMD) diagnostics with the launch of new real-time (RT) PCR assays. The newly introduced AsurDxTM Real-Time PCR kits include single, dual, and multiplex detection options for : This product line complements BioStone’s existing portfolio of competitive ELISA…
DALLAS-FORT WORTH, TX — April 2, 2025— BioStone Animal Health is pleased to announce the launch of the AsurDxTM Avian Influenza Virus H5/H7 (AIV-H5/H7) Real-Time PCR Detection Kit designed for the detection of H5 and H7 subtype of avian influenza virus RNA in tissue/throat swabs. The avian influenza virus subtypes are labeled according to an H…
DALLAS-FORT WORTH, TX — March 20, 2025— BioStone Animal Health is pleased to announce the launch of the AsurDxTM Fowl Adenovirus Group I (FADV-1, 2, 4, 8a, 8b, 11) Antibody Test Kit designed for the detection of chicken antibodies specific to Fowl Adenovirus Group I (FADV-1, 2, 4, 8a, 8b, 11) in chicken serum/plasma. Fowl Adenovirus…
DALLAS-FORT WORTH, TX — November 12, 2024— BioStone Animal Health is pleased to announce that evaluation of our AsurDx™ bELISA and iELISA for African Swine Fever (ASF) antibody was published on November 8, 2024, in the peer-reviewed journal, Pathogens [1]. The evaluation was conducted at the National Center for Foreign Animal Disease (NCFAD, Winnipeg, Canada), which is one…
DALLAS-FORT WORTH, TX — October 29, 2024— BioStone Animal Health is pleased to announce that the GenScript Life Science Research Grant Program has awarded BioStone Animal Health a grant to investigate and develop DIVA diagnostics for African swine fever (ASF). GenScript Life Science Research Grant Program (www.genscript.com ), a new initiative dedicated to supporting breakthroughs in life…
DALLAS-FORT WORTH, TX — May 3, 2024— BioStone Animal Health is pleased to announce the launch of the AsurDxTM FMDV Type SAT2 Antibody cELISA Test Kit (Bovine/Ovine/Caprine/Swine) designed for the detection of antibodies specific to multispecies of foot and mouth disease virus (FMDV) serotype SAT2 in bovine, ovine, caprine or swine origin. Foot and mouth disease…